Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Personalized Transcatheter Heart Valve Replacement
Symbiosis C.M. is an innovative medical device company dedicated to solving anatomical variability in valvular heart disease, allowing better fit and better performance for existing medical devices, as well as standalone products for anatomies with great inter-patient variability.
Symbiosis first product is ValSync, the first minimally invasive personalized solution for valve replacement.
Identity
| Name | Symbiosis C.M. |
|---|---|
| Slug | symbiosis-c-m |
| Former names | Vallus |
| Type / kind | startup |
| Source _id | zP0Sud3lJL25kamw95rKXDjZG8kWrGi4WFtXQnTWUBa49p1EexKvAi |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Petah Tikva |
| HQ address | Ha-Sivim St 18, Petah Tikva, Israel |
Web & social
| Website | https://symbiosis-cm.com/ |
|---|---|
| https://www.linkedin.com/company/82605253 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymersComponentsModular
Target customers
Healthcare & Life SciencesMedical Devices Industry
Business models
B2B
Tags
valvescardiologyminimally-invasivemedical-devicesheart-diseases
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}